Fractal Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-22,000
Closed -$455K 86
2024
Q2
$455K Hold
22,000
0.08% 41
2024
Q1
$414K Buy
+22,000
New +$378K 0.08% 47
2023
Q3
Sell
-11,500
Closed -$239K 106
2023
Q2
$239K Buy
+11,500
New +$250K 0.05% 80
2023
Q1
Sell
-25,200
Closed -$704K 99
2022
Q4
$704K Hold
25,200
0.17% 45
2022
Q3
$590K Hold
25,200
0.16% 45
2022
Q2
$851K Buy
25,200
+10,000
+66% +$350K 0.28% 33
2022
Q1
$531K Hold
15,200
0.16% 53
2021
Q4
$463K Buy
+15,200
New +$495K 0.16% 61

Other funds holding OGN

Fractal Investments's OGN Position: Q3 2024 in Review

Fractal Investments sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 22,000 shares — an estimated $455K sold.

Fractal Investments first reported a position in OGN in Q4 2021 and held it in 8 quarters. The position peaked at $851K in Q2 2022. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Fractal Investments reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Fractal Investments sold 22,000 Organon & Co shares in Q3 2024, an estimated $455K.
  • Fractal Investments first reported a position in Organon & Co in Q4 2021 and held it in 8 quarters.
  • Fractal Investments's Organon & Co position peaked at $851K in Q2 2022.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Fractal Investments's 13F filing for Q3 2024, filed 30 Oct 2024.